Pancreatic Cancer Research

ResearcherDüsseldorf University HospitalNo recent work listed

Lena Häberle

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8793-568X; OpenAlex author ID A5047876219. Sources: OpenAlex.

Their work

Papers
14 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
37
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: 3 papers · 2023: 3 papers

Papers 14

  1. A Single-Molecule Bioelectronic Portable Array for Early Diagnosis of Pancreatic Cancer Precursors. Co-author DOI 10.1002/adma.202304102↗
  2. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. Co-author DOI 10.1136/gutjnl-2021-326550↗
  3. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis. Co-author DOI 10.1186/s12943-023-01880-1↗
  4. [Pancreatic cystic space-occupying lesions-Diagnostics, treatment and follow-up care : Current recommendations taking the current German S3 guidelines on pancr… First author DOI 10.1007/s00104-022-01616-9↗
  5. Communicator-Driven Data Preprocessing Improves Deep Transfer Learning of Histopathological Prediction of Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers14081964↗
  6. Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14143494↗
  7. Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival. First author DOI 10.1016/j.pan.2021.02.024↗
  8. Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report. Co-author DOI 10.1186/s13256-021-02768-8↗
  9. Stroma composition and proliferative activity are related to therapy response in neoadjuvant treated pancreatic ductal adenocarcinoma. Co-author DOI 10.14670/hh-18-332↗
  10. Neoadjuvant Treatment Lowers the Risk of Mesopancreatic Fat Infiltration and Local Recurrence in Patients with Pancreatic Cancer. First author DOI 10.3390/cancers14010068↗
  11. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. Co-author DOI 10.15252/embj.2019102808↗
  12. Pathology of pancreatic cancer. Co-author DOI 10.21037/tgh.2019.06.02↗
  13. Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on. First author DOI 10.1016/j.pan.2018.04.010↗
  14. Stromal heterogeneity in pancreatic cancer and chronic pancreatitis. Co-author DOI 10.1016/j.pan.2018.05.004↗

Closest collaborators

The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Iréne Esposito · 14 shared papers, 2018–2023 · strength 1.96
  2. Wolfram Trudo Knoefel · 8 shared papers, 2018–2023 · strength 1.00
  3. Sami Alexander Safi · 5 shared papers, 2018–2022 · strength 0.58
  4. Alexander Rehders · 3 shared papers, 2021–2022 · strength 0.40
  5. Anna Melissa Schlitter · 3 shared papers, 2018–2023 · strength 0.37
  6. Nikolas Hendrik Stoecklein · 2 shared papers, 2023 · strength 0.28
  7. Andreas H. Krieg · 2 shared papers, 2021–2022 · strength 0.27
  8. Tom Luedde · 2 shared papers, 2021 · strength 0.25
  9. Robert Grützmann · 1 shared paper, 2022 · strength 0.22
  10. Maximilian Brunner · 1 shared paper, 2022 · strength 0.22
  11. Sven‐Thorsten Liffers · 1 shared paper, 2023 · strength 0.15
  12. Elisa Espinet Espinet · 1 shared paper, 2023 · strength 0.15
  13. Andreas Trumpp · 1 shared paper, 2023 · strength 0.15
  14. Aslihan Yavas Can · 1 shared paper, 2023 · strength 0.15
  15. Laura Godfrey · 1 shared paper, 2023 · strength 0.15
  16. Jens Thomas Siveke · 1 shared paper, 2023 · strength 0.15
  17. Günter Klöppel · 1 shared paper, 2023 · strength 0.15
  18. Christian Vay · 1 shared paper, 2022 · strength 0.15
  19. Raphael M. Kronberg · 1 shared paper, 2022 · strength 0.15
  20. Philipp Alexander Lang · 1 shared paper, 2022 · strength 0.15
  21. Andrea Cacciato Insilla · 1 shared paper, 2021 · strength 0.13
  22. Helmut Friess · 1 shared paper, 2021 · strength 0.13
  23. İhsan Ekin Demir · 1 shared paper, 2021 · strength 0.13
  24. Enrico Genco · 1 shared paper, 2023 · strength 0.13
  25. Luisa Torsi · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.